Daiwa Securities Group Inc. - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 179 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$50.0%6920.0%0.00%
Q2 2023$5
-16.7%
6920.0%0.00%
Q1 2023$6
-25.0%
6920.0%0.00%
Q4 2022$8
-99.9%
6920.0%0.00%
Q3 2022$9,000
+28.6%
6920.0%0.00%
Q2 2022$7,000
-22.2%
692
+31.8%
0.00%
Q1 2022$9,000
+28.6%
5250.0%0.00%
Q4 2021$7,000
-22.2%
525
-14.4%
0.00%
Q3 2021$9,000
+80.0%
613
+84.6%
0.00%
Q2 2021$5,000
+66.7%
3320.0%0.00%
Q1 2021$3,000
+50.0%
3320.0%0.00%
Q4 2020$2,000
-33.3%
332
-66.3%
0.00%
Q3 2020$3,000
+50.0%
986
+13.5%
0.00%
Q2 2020$2,0000.0%8690.0%0.00%
Q1 2020$2,000
-33.3%
8690.0%0.00%
Q4 2019$3,000
+50.0%
869
+24.7%
0.00%
Q3 2019$2,000
-33.3%
6970.0%0.00%
Q2 2019$3,000
-50.0%
6970.0%0.00%
Q1 2019$6,000
+50.0%
697
+28.1%
0.00%
Q4 2018$4,0000.0%5440.0%0.00%
Q3 2018$4,000
+33.3%
5440.0%0.00%
Q2 2018$3,0000.0%5440.0%0.00%
Q1 2018$3,0005440.00%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Burrage Capital Management LLC 1,105,673$8,237,0006.28%
Sarissa Capital Management LP 8,175,000$60,903,0006.22%
ORACLE INVESTMENT MANAGEMENT INC 2,980,870$22,207,0002.78%
DG Capital Management, LLC 1,075,732$8,014,0001.70%
Ghost Tree Capital, LLC 900,000$6,705,0001.49%
Parkman Healthcare Partners LLC 538,370$4,011,0001.03%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,835,810$43,477,0000.86%
Formidable Asset Management, LLC 470,419$3,470,0000.80%
KNOTT DAVID M 219,461$1,635,0000.74%
Altium Capital Management LP 250,000$1,863,0000.70%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders